Anadis

Anadis (ANX)

Stock Code

ANX

Stock Exchange

ax

Anadis (ANX) is a bio-pharmaceutical research and development company. The company's principal activities incorporate the use of polyclonal antibodies for the treatment and prevention of key diseases. Its products offer immediate-acting, surface-based immune protection, which are considered to speed up the repair of damaged gastrointestinal mucosa, damaged due to disease, toxins or radiation, by lessening the bodies own local inflammatory processes that contribute to such damage. Anadis listed on ASX on April 30, 1999.

Syndicate content

Recommended Websites